Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AVANOS MEDICAL, INC. | Director | Common Stock | 59.6K | $1.26M | $21.15 | Jan 3, 2024 | Direct |
ReShape Lifesciences Inc. | Director | Common Stock, $0.001 par value per share | 253K | $68.4K | $0.27 | Jul 22, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVNS | AVANOS MEDICAL, INC. | Jan 3, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
AVNS | AVANOS MEDICAL, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
AVNS | AVANOS MEDICAL, INC. | Jan 3, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Director |
RSLS | ReShape Lifesciences Inc. | Jul 22, 2021 | 1 | $0 | 4 | Sep 17, 2021 | Director |
RSLS | ReShape Lifesciences Inc. | Jun 15, 2021 | 0 | $0 | 3 | Jun 24, 2021 | Director |